AKT1 and breast carcinoma: Western blot analysis indicated that rapamycin treatment reversed the increase in the accumulation of activated (i.e., phosphorylated) AKT/mTOR proteins observed in ATRAP-overexpressing breast cancer cell lines (Figure 3A).